US equities
|
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Immuno/Oncology
Recent news which mentions Immuno/Oncology
Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials
January 12, 2022
Tickers
ALKS
Tags
NASDAQ:ALKS
Immuno/Oncology
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
December 06, 2021
Tickers
BOLT
Tags
Small Cap
Phase 1 Trial
Trading Ideas
From
Benzinga
Gilead Wins Reversal of $1.2B Patent Loss to Bristol-Myers: Bloomberg
August 26, 2021
Tickers
BMY
GILD
Tags
News
Market News
BMY
From
Benzinga
iBio Expands Immuno-Oncology Pipeline With RubrYc Deal
August 25, 2021
Tickers
IBIO
Tags
Health Care
Briefs
Benzinga
From
Benzinga